These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30795991)

  • 1. Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions.
    Tripathi PN; Srivastava P; Sharma P; Seth A; Shrivastava SK
    Bioorg Med Chem; 2019 Apr; 27(7):1327-1340. PubMed ID: 30795991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions.
    Mishra P; Sharma P; Tripathi PN; Gupta SK; Srivastava P; Seth A; Tripathi A; Krishnamurthy S; Shrivastava SK
    Bioorg Chem; 2019 Aug; 89():103025. PubMed ID: 31176239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.
    Tripathi A; Choubey PK; Sharma P; Seth A; Tripathi PN; Tripathi MK; Prajapati SK; Krishnamurthy S; Shrivastava SK
    Eur J Med Chem; 2019 Dec; 183():111707. PubMed ID: 31561043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
    Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
    Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease.
    Choubey PK; Tripathi A; Tripathi MK; Seth A; Shrivastava SK
    Bioorg Chem; 2021 Jun; 111():104922. PubMed ID: 33945941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Molecular Hybrids of
    Sharma P; Tripathi A; Tripathi PN; Singh SS; Singh SP; Shrivastava SK
    ACS Chem Neurosci; 2019 Oct; 10(10):4361-4384. PubMed ID: 31491074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Aβ-aggregation inhibitors: Synthesis and biological evaluation.
    Mohamed T; Yeung JC; Rao PP
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5881-7. PubMed ID: 21873056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease.
    Sharma P; Tripathi A; Tripathi PN; Prajapati SK; Seth A; Tripathi MK; Srivastava P; Tiwari V; Krishnamurthy S; Shrivastava SK
    Eur J Med Chem; 2019 Apr; 167():510-524. PubMed ID: 30784883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Jiang N; Huang Q; Liu J; Liang N; Li Q; Li Q; Xie SS
    Eur J Med Chem; 2018 Feb; 146():287-298. PubMed ID: 29407958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy.
    Verma A; Waiker DK; Singh N; Roy A; Singh N; Saraf P; Bhardwaj B; Krishnamurthy S; Trigun SK; Shrivastava SK
    ACS Chem Neurosci; 2024 Feb; 15(4):745-771. PubMed ID: 38327209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory.
    Tripathi PN; Srivastava P; Sharma P; Tripathi MK; Seth A; Tripathi A; Rai SN; Singh SP; Shrivastava SK
    Bioorg Chem; 2019 Apr; 85():82-96. PubMed ID: 30605887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Xu YX; Wang H; Li XK; Dong SN; Liu WW; Gong Q; Wang TD; Tang Y; Zhu J; Li J; Zhang HY; Mao F
    Eur J Med Chem; 2018 Jan; 143():33-47. PubMed ID: 29172081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, in vitro and in vivo evaluation of novel pyrrolizine-based compounds with potential activity as cholinesterase inhibitors and anti-Alzheimer's agents.
    El-Sayed NA; Farag AE; Ezzat MAF; Akincioglu H; Gülçin İ; Abou-Seri SM
    Bioorg Chem; 2019 Dec; 93():103312. PubMed ID: 31586715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design and synthesis of dihydropyrimidine based dual binding site acetylcholinesterase inhibitors.
    Ahmad S; Iftikhar F; Ullah F; Sadiq A; Rashid U
    Bioorg Chem; 2016 Dec; 69():91-101. PubMed ID: 27750058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
    Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
    Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
    Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B
    Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
    Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
    Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and evaluation of novel N-(4-phenoxybenzyl)aniline derivatives targeting acetylcholinesterase, β-amyloid aggregation and oxidative stress to treat Alzheimer's disease.
    Srivastava P; Tripathi PN; Sharma P; Shrivastava SK
    Bioorg Med Chem; 2019 Aug; 27(16):3650-3662. PubMed ID: 31288978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Tan Z
    Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.